Relizen Review: Ingredients, Research, and Questions to Ask

We may earn money or products from the companies mentioned in this post.

Hot flashes and night sweats can make a supplement subscription feel tempting. Before paying for Relizen, it helps to separate the formula, the marketing, the research, and the recurring cost.

This Relizen review is based on published research and product information, not personal product testing. It explains what the selected studies can establish, where uncertainty remains, and what to discuss with a healthcare professional.

This article provides general educational information and does not replace individualized medical advice.

Quick Verdict: What the Evidence Can Establish

Quick verdict: Some studies of purified pollen preparations report symptom improvements, but they do not establish that current Relizen reliably treats hot flashes during perimenopause. Formulation, study design, and participant differences matter. Review the evidence and your health history with a clinician before purchasing.

The 2023 nonhormone therapy position statement from The North American Menopause Society, now The Menopause Society, did not recommend supplements or herbal remedies for vasomotor symptoms, meaning hot flashes and night sweats. Positive findings from an individual study should not be presented as a clinical recommendation.

This does not establish that every person will have the same experience. It does mean the review should distinguish promising results from dependable treatment evidence.

What Relizen Is and What the Manufacturer Says

Bonafide markets Relizen as a hormone-free supplement for menopausal hot flashes and night sweats. Its official product page describes a purified Swedish flower pollen blend.

Manufacturer statements establish how the product is described and sold. They do not independently establish an individual’s likely benefit. Hormone-free should not be interpreted as risk-free or as proof of suitability for a particular medical history.

Ingredients and Current Label Information

Product information checked November 3, 2026. Bonafide lists a proprietary cytoplasmic blend comprising pollen and pistil extract PI-82 and pollen extract GC-FEM (Sérélys). Other ingredients include isomalt, maltodextrin, microcrystalline cellulose, acacia, magnesium stearate, vitamin E, HPMC, silica, and polysorbate.

The page describes two tablets daily. This is manufacturer information, not individualized dosing advice. Verify the current package’s complete Supplement Facts panel, ingredient quantities, serving size, and warnings; do not infer an undisclosed amount.

An ingredient list alone cannot establish whether a product will cause digestive symptoms in an individual. A pharmacist can assess the full label, ingredient quantities, and relevant sensitivities.

What to Check Before Buying

The complete ingredient list and quantities shown on the current package
Serving size and supply duration for the purchase option selected
Label warnings and your allergy history
Whether pregnancy, breastfeeding, cancer treatment, or medicines require a separate clinical review

Research Findings and Limitations

The key question is not simply whether pollen has been studied. It is whether the study tested the same preparation, in a relevant population, with a comparison capable of answering the claim being made.

The summaries below describe selected published abstracts and clinical guidance. They are not a systematic review or an assessment of every full-text paper. Funding and conflict-of-interest information was not established for every study reviewed; lack of a statement here should not be interpreted as proof of independence.

The 2005 Placebo-Controlled Femal Trial

Winther and colleagues’ 2005 trial enrolled 64 menopausal women; 54 completed the study. Participants received Femal, a pollen preparation, or placebo for three months after a run-in period. The abstract reports improvement in hot-flash outcomes favoring active treatment.

This is relevant controlled evidence, but it concerns Femal rather than an independently verified match to every feature of current Relizen. Its size and duration limit conclusions about uncommon adverse effects, long-term outcomes, and applicability to women in perimenopause. A positive study is not a guarantee of benefit.

The 2008 Femal Trial Was About PMS

The Gerhardsen study cited in Bonafide’s references evaluated Femal for premenstrual sleep disturbances in women with premenstrual syndrome. That research question differs from menopausal hot flashes. It should not be counted as direct proof that Relizen treats hot flashes during perimenopause.

The 2020 Observational Comparison

A six-month observational study compared 57 women receiving a pollen preparation, 60 receiving soy isoflavones, and 47 receiving no treatment. It reported improvements in symptoms and sleep measures, with some later comparisons favoring pollen.

This was an observational comparison, not a randomized placebo-controlled trial. Differences between groups, expectations, and other factors can influence results. It also studied women in natural menopause, so it cannot by itself settle effectiveness in perimenopause.

The 2022 Study Included Perimenopausal Women

A multicenter prospective observational study published in 2022 included 108 peri- and postmenopausal women. Symptoms improved after three months of purified pollen treatment.

This is directly relevant to the question of perimenopausal inclusion, so saying the research contains no such participants would be inaccurate. However, the before-and-after design does not establish that the preparation caused the improvement. It is not a randomized placebo comparison or proof that every current commercial formulation is equivalent.

Evidence at a Glance

Evidence	What it contributes	Main limitation
2005 Femal trial	A small randomized placebo comparison with favorable hot-flash findings	Related preparation, limited size and duration
2008 Femal trial	Research on premenstrual sleep disturbances	PMS is a different population and outcome
2020 pollen comparison	Observational symptom and sleep findings	Not a randomized placebo-controlled trial
2022 peri- and postmenopause study	Includes perimenopausal participants	Before-and-after findings cannot establish causation
Customer testimonials or surveys	Describe reported experiences	Selection, expectations, and lack of a control group limit interpretation
Clinical guidance	Places the total evidence in treatment context	Recommendations address a broader evidence base, not an individual’s guaranteed response

Do not combine percentages from trials, surveys, and testimonials as though they measure the same outcome. Response rates, average symptom changes, and satisfaction are different measures. Likewise, a large customer survey does not become a randomized trial because many people responded.

What Medical Guidance Says

The 2023 position statement identifies evidence-supported hormonal and nonhormonal approaches while not recommending supplements or herbal remedies for hot flashes. The Society’s patient guidance specifically includes pollen extract among approaches with limited solid evidence or a lack of significant benefit in clinical trials.

Use that context when discussing options. This review does not select a treatment, recommend stopping a medicine, or establish that a supplement is interchangeable with prescription therapy.

Safety Considerations and Questions for a Clinician

Woman discussing symptom notes with a medical professional wearing glasses and a white coat.

Allergy history: Have a clinician or pharmacist review the actual formulation and your specific reactions. Do not assume that purified flower pollen, bee-collected pollen, royal jelly, and propolis are interchangeable products, or that the word pollen alone establishes whether you will react.

Cancer history or treatment: Memorial Sloan Kettering’s pollen-extract resource notes that studies in cancer populations are needed to establish safety and effectiveness. A hormone-free claim does not replace your oncology team’s assessment, including possible interactions with cancer therapy.

Medications, pregnancy, and breastfeeding: Bring the complete label and your medication and supplement list to a healthcare professional. This review does not establish suitability in these situations or the absence of interactions. The presence of vitamin E on an ingredient list, without establishing its quantity and your circumstances, is not enough to predict an interaction.

Possible adverse reactions: Stop using a product and seek medical advice if a reaction occurs. Trouble breathing, throat or tongue swelling, or fainting can indicate a severe allergic reaction. Call 911 for a serious allergic reaction in the United States.

FDA registration is not product approval: The FDA explains that dietary supplements are not approved for safety and effectiveness before marketing. A registered facility or a manufacturing-quality claim does not establish FDA approval of Relizen or its symptom claims.

Questions to Bring to an Appointment

Could another condition or medicine explain these symptoms?
Which options have evidence relevant to my medical history?
Does this complete ingredient list raise any concerns with my medicines or allergies?
If we consider a supplement, what should I track, when should we reassess, and what would prompt stopping?

One-Time Pricing Versus Subscription Costs

Official prices checked November 3, 2026; US dollars before tax. These are the displayed options, not a recommendation to purchase:

Option	Advertised monthly equivalent	Amount billed	Listed shipping
One-time purchase	Not a subscription	$58	$5
Monthly plan	$42	$42 monthly	Free
Quarterly plan	$38	$114 quarterly	Free
Six-month plan	$33	$198 semiannually	Free

Source: Bonafide Relizen. Confirm supply, tablet count, shipping, renewal, and cancellation terms for the selected option at checkout. Prices can change.

The monthly equivalent and the payment due today are different figures. A lower advertised monthly cost can require a larger upfront commitment. Compare the total commitment and return terms rather than choosing from the monthly headline alone.

This review does not calculate a cost per serving because that requires confirming the exact supply attached to the selected option. Do not assume that a quantity initially displayed on a product page applies to every purchase option.

Subscription Terms to Review

How and when cancellation or changes must be requested
The next billing date and shipment frequency
Whether the discount continues on later orders
Whether opened or unopened products qualify for a refund
The exact quantity and supply included in the charge

Keep a copy of the terms you accept. The appropriate commitment depends on your budget and clinical discussion; a study duration is not an instruction to purchase that much product or to continue through adverse effects.

Research-Based Pros and Limitations

Potential Positives

The formulation and intended use can be checked against an official product source.
Published research on related pollen preparations includes controlled and observational studies.
The evidence can be discussed with a clinician using identifiable study designs rather than testimonials alone.

Limitations

Results from a related preparation do not automatically establish results for the current product.
Observational findings cannot establish treatment effects in the same way as a well-conducted randomized placebo comparison.
Some cited research addresses PMS rather than menopausal hot flashes.
Selected studies do not settle long-term safety, individual suitability, or effectiveness during perimenopause.
Upfront payments and automatic renewals can make an uncertain benefit costly.
The clinical guidance reviewed does not recommend supplements as hot-flash treatments.

Questions to Ask Before Purchasing

Start with the study behind a claim: which preparation, which participants, what comparison, and what outcome? Check funding and disclosures in the full publication before labeling a trial independent.

Next, review the complete package label and any claimed quality certification. A general statement about third-party testing is different from a named certification for a specific product, and testing for identity or contaminants does not establish symptom relief.

If a clinician agrees that trying a supplement is appropriate, discuss tracking and reassessment in advance. Note hot-flash frequency and severity, sleep disruption, and daily impact. Use whatever notes you already have; do not postpone necessary care to complete a fixed tracking period.

Our perimenopause supplement comparison covers other formulations and evidence gaps. Our guide to when perimenopause starts explains timing and what to track. These provide context rather than a substitute for an assessment.

Frequently Asked Questions

Does the Research Include Perimenopause?

Yes, the 2022 observational study included both peri- and postmenopausal women. That improves its relevance to this question, but the design and formulation limitations remain. Inclusion is not the same as strong proof of effectiveness for current Relizen during perimenopause.

How Long Does Relizen Take to Work?

Bonafide’s page suggests at least three months. That is manufacturer guidance, not a guaranteed response or a universal trial period. Discuss reassessment and stopping criteria with a clinician; do not continue through adverse effects to reach an advertised timeframe.

Is It Suitable for Someone With Allergies?

This review cannot determine that. Have the actual label and your specific allergy history assessed. Avoid conclusions based only on whether a product is described as natural, purified, or pollen-based.

Is It Equivalent to Hormone Therapy?

No direct equivalence is established by the selected evidence. The 2023 position statement describes hormone therapy as the most effective treatment for vasomotor symptoms and identifies evidence-supported nonhormonal options. Individual risks, preferences, and suitability require a clinician’s assessment.

Can It Be Taken With Other Medicines?

Do not assume compatibility. A pharmacist or clinician should review the complete formulation alongside all your medicines and supplements. This article does not evaluate individual combinations.

Conclusion: A Practical Decision Checklist

The useful question is whether the research, label, cost, and clinical context answer your concerns well enough to make an informed decision. A favorable testimonial or the term hormone-free cannot answer those questions alone.

Before purchasing:

Verify the full current package label and selected supply.
Review your medical history, allergies, and medicines with a clinician or pharmacist.
Ask whether the studies match the current formula and your stage of life.
Compare the payment due today with renewal and refund terms.
Discuss tracking, reassessment, and reasons to stop if a trial is considered appropriate.
Ask about options with stronger evidence for the symptom that is affecting you.

If symptoms are disrupting sleep, work, or mood, seek clinical advice rather than allowing repeated supplement purchases to delay assessment.

This research-based review is educational and does not replace medical advice, diagnosis, or treatment. No personal product testing is claimed. Product details and prices may change.